Combined oncolytic and vaccination activities of parvovirus H-1 in a metastatic tumor model

Oncology Reports

Volumn 17, Issue 6, 2007, Pages 1493-1499

  Raykov, Zahari ^a   Grekova, Svetlana ^a   Galabov, Angel S ^b   Balboni, Ginette ^c   Koch, Ute ^d   Aprahamian, Marc ^c   Rommelaere, Jean ^a  

^a GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^b BULGARIAN ACADEMY OF SCIENCES   (Bulgaria)

^c IRCAD   (France)

^d SWISS INST FOR EXP CANCER RESEARCH   (Switzerland)

Author keywords

Cancer; Metastases; Oncolysis; Parvovirus; Vaccination

Indexed keywords

CANCER VACCINE; ONCOLYTIC VIRUS; VIRUS ANTIBODY;

ANIMAL; ARTICLE; DRUG EFFECT; DRUG SCREENING; IMMUNOLOGY; LUNG TUMOR; METASTASIS; ONCOLYTIC VIROTHERAPY; PARVOVIRUS H1; PHYSIOLOGY; RAT; RAT STRAIN; TUMOR CELL LINE;

ANIMALS; ANTIBODIES, VIRAL; CANCER VACCINES; CELL LINE, TUMOR; H-1 PARVOVIRUS; LUNG NEOPLASMS; ONCOLYTIC VIROTHERAPY; ONCOLYTIC VIRUSES; RATS; RATS, INBRED STRAINS; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 34548052482     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.17.6.1493     Document Type: Article

References (22)

1. Liotta LA and Stetler-Stevenson WG: Principles of molecular cell biology of cancer: cancer metastasis. In: Cancer: Principles and Practice of Oncology. DeVita VT Jr, Hellman S and Rosenberg SA (eds). JB Lippincott, Philadelphia, pp134-149, 1993.
2. Anderson PM, Markovic SN, Sloan JA, et al: Aerosol granulocyte macrophage-colony stimulating factor: A low toxicity, lung-specific biological therapy in patients with lung metastases. Clin Cancer Res 5: 2316-2323, 1999. (Pubitemid 29437308)
3. Koshkina NV, Kleinerman ES, Waldrep C, Jia SF, Worth LL, Gilbert BE and Knight V: 9-Nitrocamptothecin liposome aerosol treatment of melanoma and osteosarcoma lung metastases in mice. Clin Cancer Res 6: 2876-2880, 2000. (Pubitemid 30482130)
4. Worth LL, Jia SF, Zhou Z, Chen L and Kleinerman ES: Intranasal therapy with an adenoviral vector containing the murine interleukin-12 gene eradicates osteosarcoma lung metastases. Clin Cancer Res 6: 3713-3718, 2000.
5. Haag A, Menten P, Van Damme J, Dinsart C, Rommelaere J and Cornelis J: Highly efficient transduction and expression of cytokine genes in human tumor cells by means of autonomous parvovirus vectors; generation of antitumor responses in recipient mice. Hum Gene Ther 11: 597-609, 2000. (Pubitemid 30134303)
6. Rommelaere J and Cornelis J: Antineoplastic activity of parvoviruses. J Virol Methods 33: 233-251, 1991.
7. Russell SJ, Brandenburger A, Flemming CL, Collins MK and Rommelaere J: Transformation-dependent expression of interleukin genes delivered by a recombinant parvovirus. J Virol 66: 2821-2828, 1992.
8. Cornelis JJ, Becquart P, Duponchel N, Salome N, Avalosse BL, Namba M and Rommelaere J: Transformation of human fibroblasts by ionizing radiation, a chemical carcinogen, or simian virus 40 correlates with an increase in susceptibility to the autonomous parvoviruses H-1 virus and minute virus of mice. J Virol 62: 1679-1686, 1988.
9. Raykov Z, Balboni G, Aprahamian M and Rommelaere J: Carrier cell-mediated delivery of oncolytic parvoviruses for targeting metastases. Int J Cancer 109: 742-749, 2004. (Pubitemid 38405623)
10. Schirrmacher V, Griesbach A and Ahlert T: Antitumor effects of Newcastle Disease Virus in vivo: local versus systemic effects. Int J Oncol 18: 945-952, 2001.
11. Schirrmacher V, Bai L, Umansky V, Yu L, Xing Y and Qian Z: Newcastle disease virus activates macrophages for anti-tumor activity. Int J Oncol 16: 363-373, 2000.
12. Schirrmacher V: Clinical trials of antitumor vaccination with an autologous tumor cell vaccine modified by virus infection: improvement of patient survival based on improved antitumor immune memory. Cancer Immunol Immunother 54: 587-598, 2005.
13. Lang S, Giese N, Rommelaere J, Dinsart C and Cornelis J: Humoral immune responses against minute virus of mice vectors. J Gene Med: (in press).
14. Rosel M, Claas C, Seiter S, Herlevsen M and Zoller M: Cloning and functional characterization of a new phosphatidyl-inositol anchored molecule of a metastasizing rat pancreatic tumor. Oncogene 17: 1989-2002, 1998. (Pubitemid 28488468)
15. Giese NA, Gazzinelli RT, Actor JK, Morawetz RA, Sarzotti M and Morse HC III: Retrovirus-elicited interleukin-12 and tumour necrosis factor-alpha as inducers of interferon-gamma-mediated pathology in mouse AIDS. Immunology 87: 467-474, 1996.
16. Olivenstein R, Renzi PM, Yang JP, Rossi P, Laberge S, Waserman S and Martin JG: Depletion of OX-8 lymphocytes from the blood and airways using monoclonal antibodies enhances the late airway response in rats. J Clin Invest 92: 1477-1482, 1993. (Pubitemid 23273927)
17. + cells are not necessary for allograft rejection or the induction of apoptosis in an experimental model of small intestinal transplantation. J Immunol 160: 3673-3680, 1998.
18. Moehler MH, Zeidler M, Wilsberg V, et al: Parvovirus H-1-induced tumor cell death enhances human immune response in vitro via increased phagocytosis, maturation, and cross-presentation by dendritic cells. Hum Gene Ther 16: 996-1005, 2005. (Pubitemid 41153868)
19. Albert ML: Death-defying immunity: do apoptotic cells influence antigen processing and presentation? Nat Rev Immunol 4: 223-231, 2004.
20. Siegl G: Biology and pathogenicity of autonomous parvoviruses. In: The Parvoviruses. Berns KI (ed). Plenum Press, New York, pp297-362, 1984.
21. Wetzel K, Menten P, Opdenakker G, Van Damme J, Grone HJ, Giese N, Vecchi A, Sozzani S, Cornelis JJ, Rommelaere J and Dinsart C: Transduction of human MCP-3 by a parvoviral vector induces leukocyte infiltration and reduces growth of human cervical carcinoma cell xenografts. J Gene Med 3: 326-337, 2001. (Pubitemid 33691772)
22. Giese NA, Raykov Z, DeMartino L, Vecchi A, Sozzani S, Dinsart C, Cornelis JJ and Rommelaere J: Suppression of metastatic hemangiosarcoma by a parvovirus MVMp vector transducing the IP-10 chemokine into immunocompetent mice. Cancer Gene Ther 9: 432-442, 2002. (Pubitemid 34438585)